October 17, 2023
The University of Cincinnati Cancer Center has joined the National Cancer Institute’s Experimental Therapeutics Clinical Trials Network (ETCTN), providing patients with access to cutting edge treatments only available through the network.
November 16, 2023
The University of Cincinnati Gardner Neuroscience Institute's Brandon Foreman recently published survey results identifying areas of consensus and needs for further research to develop a standard practice for comprehensively monitoring brain health in the intensive care unit.
February 20, 2024
KFVS-TV in Cape Girardeau, Missouri highlighted a University of Cincinnati clinical trial testing a wearable neurostimulation device to help patients with opioid use disorder and post-traumatic stress disorder stick with medication treatment while finding the right dose.
February 19, 2024
Local 12 and the Cincinnati Business Courier highlighted the University of Cincinnati Cancer Center's Blood Cancer Healing Center, a comprehensive all-in-one facility dedicated solely to advancing research, treatment and wellness for blood cancer patients, opening this summer.
January 11, 2024
WVXU highlighted a new trial at the University of Cincinnati that will test an at-home tongue endurance exercise to improve patients’ swallowing function after a stroke.
April 12, 2024
University of Cincinnati researchers will present abstracts at the American Academy of Neurology annual meeting 2024, April 13-18 in Denver, Colorado.
January 6, 2021
WVXU reporter Michael Monks spoke to UC faculty members, Dustin Calhoun, MD, and Louito Edje, MD, for a Cincinnati Edition story discussing the process for COVID-19 vaccination in Cincinnati and hesitancy that some residents have in receiving that protective measure. Ohio residents age 65 and older, school employees and people with medical conditions that put them at high-risk will be eligible for the COVID-19 vaccine in about two weeks.
September 12, 2022
Technology from a University of Cincinnati Venture Lab-backed startup could save lives by allowing emergency medical personnel to accurately monitor the life-saving treatment they provide.
July 9, 2024
Medscape highlighted research led by the University of Cincinnati's Jason McMullan that found adding intranasal ketamine to fentanyl does not improve pain scores in patients with out-of-hospital trauma injuries.
October 25, 2022
National media outlets highlighted the results of the first-in-human trial of FLASH radiotherapy, led by University of Cincinnati Cancer Center researchers.